Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE191293 | GEO | 2024/12/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis [XCON/XCKO hepatocytes]

Project description:Our study demonstrated that XBP1 is upregulated in liver tissues of patients with NASH. Conditional knockout of Xbp1 in the hepatocytes resulted in decreased lipid accumulation in mice. Genetic specific deletion of Xbp1 in macrophages ameliorated nutritional steatohepatitis and fibrosis in mice by reducing the secretion of pro-inflammatory cytokine, increasing M2 macrophage polarization, and decreasing TGF-β1 expression. Pharmacological inhibition of XBP1 protects against steatohepatitis and fibrosis, highlighting a promising strategy for NASH therapy.

2024-12-17 | GSE191292 | GEO

The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis [XWT/XKO BMDMs]

2024-12-17 | GSE191291 | GEO

The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis

Project description:The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis

| PRJNA790869 | ENA

Transcriptional regulation of liver lipotoxicity in non-alcoholic steatohepatitis

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-07-13 | GSE173736 | GEO

XCR1+ type 1 conventional dendritic cells drive liver pathology in Non-Alcoholic Steatohepatitis.

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-05-21 | GSE169447 | GEO

The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis [XCON/XCKO hepatocytes]

Project description:The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis [XCON/XCKO hepatocytes]

| PRJNA790916 | ENA

The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis [XWT/XKO BMDMs]

Project description:The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis [XWT/XKO BMDMs]

| PRJNA790917 | ENA

Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-02-02 | GSE208706 | GEO

Rapid recapitulation of non-alcoholic steatohepatitis upon loss of HCF-1 function in mouse hepatocytes

Project description:This SuperSeries is composed of the SubSeries listed below.

2019-02-27 | GSE115768 | GEO

Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling.

Project description:Nuclear-erythroid-2-related factor 2 (Nrf2) is involved in the pathogenesis of different liver diseases. Herein, we first demonstrated that Nrf2 expression was diminished in nonalcoholic steatohepatitis (NASH) liver macrophages. In myeloid Nrf2-deficiency mice, aggravated liver steatosis and inflammation in high-fat-diet (HFD)-fed mice were observed compared with the chow-diet group. Moreover, the increasing inflammatory cytokines influenced the lipid metabolism in hepatocytes in vivo and in vitro. Further study showed Nrf2 regulated reactive-oxygen-species-mediated Hippo-yes-associated protein (YAP) signaling, which in turn modulated the NLRP3 inflammasome activation. Administration of YAP activator also significantly ablated the lipid accumulation and inhibited the NLRP3 activation in the Nrf2 deletion condition both in vitro and vivo. Overexpression Nrf2 in liver macrophages effectively alleviated steatohepatitis in wild-type mice fed with an HFD . Our data support that by modulating YAP-mediated NLRP3 inflammasome activity, macrophage Nrf2 slows down NASH progression.

| S-EPMC8141901 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data